NCT04419480 - Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Cardiogenic ShockHeart FailureAmbulatory Hemodynamic Monitoring

Interventions

DEVICE

CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization

Implantation of CardioMEMS Device in patients following admission for Cardiogenic shock, with regular ambulatory pulmonary artery pressure monitoring and medication optimization for the treatment of heart failure.

Trial Locations (1)

22042

RECRUITING

Inova Fairfax Medical Campus, Falls Church